miscsubjectsAI governance
Evidence review

Semaglutide and Gabapentin: Metabolic Load, Weight Effects, and Repair-vs-Suppression Framing

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `semaglutide-gabapentin`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/semaglutide-gabapentin

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/semaglutide-gabapentin/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/semaglutide-gabapentin/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/semaglutide-gabapentin/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/semaglutide-gabapentin/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have Gabapentin / pregabalin

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why Semaglutide might help you

  1. You are reading about Gabapentin / pregabalin — what breaks down matters before any compound name.
  2. What keeps failing: Weight-related joint and disc overload; metabolic stress on repair capacity.
  3. What Semaglutide is studied to do: Studied for GLP-1-driven weight loss — reduces mechanical load on weight-sensitive tissues.
  4. Therefore for you: If that layer is part of your problem, Semaglutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.

Why Gabapentin / pregabalin matters for you

  1. Drug: Gabapentin / pregabalin
  2. What it does: Masks neuropathic pain signal; does not repair nerve.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • Semaglutide → metabolic load / body weight

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 4
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 6

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.55 / 1.00 — moderate — human claims present in ledger

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Is Weight Gain a Side Effect of Gabapentin? (source s10)

Reports trial incidence and magnitude of gabapentin weight gain.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Emerging Clinical Roles of Gabapentin and Adverse Effects... (source s15)

Narrative review citing higher-end incidence and mechanisms.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Does gabapentin cause weight gain? (source s17)

Additional trial-based incidence data.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Gabapentin · drug map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 6 sources · swipe →chain 7ee405db0179 · verify chain · provenance
Evidence ledger 4 · tier-ranked · API
human
Gabapentin is associated with weight gain in 2% to 25% of users across trial and review data, with proposed mechanisms of appetite increase, edema, and fatigue.
sources: s10, s15, s17
human
Semaglutide produces 10-15% average body weight loss in RCTs versus placebo over 68 weeks.
sources: s2
human
No human trials test semaglutide specifically for gabapentin-induced weight gain or tissue repair outcomes.
humanlow confidence
No pharmacokinetic interactions reported between semaglutide and gabapentin in drug-interaction databases.
sources: s9, s0
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 00:28
Semaglutide and Gabapentin: Metabolic Load, Weight Effects, and Repair-vs-Suppression Framing · 4 claims · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Semaglutide for Gabapentin
Slug: semaglutide-gabapentin
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"Gabapentin / pregabalin","condition_key":"gabapentin-lyrica","primary_peptide":"semaglutide","peptides_in_scope":[{"id":"semaglutide","name":"Semaglutide"}],"drugs_in_scope":["gabapentin-lyrica"],"weight_sensitive":false,"stimulant_context":false,"breaki
it output
{"slug":"semaglutide-gabapentin","title":"Semaglutide and Gabapentin: Metabolic Load, Weight Effects, and Repair-vs-Suppression Framing","body":"## What's breaking down if you have Gabapentin / pregabalin\n\nGabapentin and pregabalin primarily act by binding to voltage-gated calcium channels. This reduces excitatory neurotransmitter release. The result is dampened nerve signaling. \n\nIf you take these drugs, the main layer that can shift is metabolic. Clinical reports show weight gain occurs in a subset of users. One review notes effects in up to 25% of patients. Another analysis of trial data puts the figure near 2%. Mechanisms discussed include increased appetite, fluid retention or edema, and reduced activity from sedation or fatigue. \n\nWeight gain adds mechanical stress to joints and the spine. Each extra pound of body weight can transmit roughly four pounds of compressive force through the lumbar discs during activity. Over time this may outpace natural repair capacity in weight-sensitive tissues. \n\nThe drug itself does not target tissue repair. It masks the pain signal. Any downstream metabolic change therefore sits outside its direct action.\n\n## Why Semaglutide might help you\n\n1. You are reading about Gabapentin / pregabalin — what breaks down matters before any compound name.\n2. What keeps failing: Weight-related joint and disc overload plus metabolic stress o
8df15af4176d6f22
Machine verification: /api/articles/semaglutide-gabapentin/contributions
Ask this article · 6 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Gabapentin is associated with weight gain in 2% to 25% of users across trial and review data, with proposed mechanisms of appetite increase,…"?
ask semaglutide-gabapentin claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "Semaglutide produces 10-15% average body weight loss in RCTs versus placebo over 68 weeks."?
ask semaglutide-gabapentin claim c3 · paste includes §SELF
What does the ledger say about this (human tier): "No human trials test semaglutide specifically for gabapentin-induced weight gain or tissue repair outcomes."?
ask semaglutide-gabapentin claim c4 · paste includes §SELF
What does the ledger say about this (human tier): "No pharmacokinetic interactions reported between semaglutide and gabapentin in drug-interaction databases."?
ask semaglutide-gabapentin claim c1 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about Semaglutide and Gabapentin: Metabolic Load, Weight Effects, and Repair-vs-Suppression Framing — and what would you need me to tell you first?
ask semaglutide-gabapentin condition gaps · paste includes §SELF
What good and bad outcomes are documented for Semaglutide and Gabapentin: Metabolic Load, Weight Effects, and Repair-vs-Suppression Framing (studies vs anecdotes)?
ask semaglutide-gabapentin good bad experiences · paste includes §SELF
semaglutide-gabapentin · posted 2026-06-29 · updated 2026-07-17 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 2 model passes · 16950 tokens · $0 · 2 models
chain head 5e3cb4f64cf86418
write grok/grok-4.3 · 2026-06-30 00:28 · 16950 tok · b7070ac2d95e
voxel_divide owner · 2026-07-17 02:41 · 0 tok · 5e3cb4f64cf8
verify chain →
Live ledger · 5 payloads · 1 turn
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-20 02:36
JCI_CLASSIFY jci · HTTP 200 · 2026-07-19 10:42
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 10:42
PROTOCOL_RUN dispatch · 2026-06-30 00:28 · t_glh1pv44
PROTOCOL_RUN dispatch · 2026-06-30 00:28 · t_glh1pv44
view full ledger & cards →
REST + ledger
read GET /api/articles/semaglutide-gabapentin · GET /api/articles/semaglutide-gabapentin?format=post (the editable body)
create/replace POST /api/articles/semaglutide-gabapentin · PUT /api/articles/semaglutide-gabapentin (replace, keeps revision) · PATCH /api/articles/semaglutide-gabapentin (merge)
delete DELETE /api/articles/semaglutide-gabapentin
writes need header x-terminal-key
LLM bundle GET /api/articles/semaglutide-gabapentin/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim semaglutide-gabapentin|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…